Efficacy Study of High Dose Symlin to Treat Type 2 Diabetes Mellitus

Clinical trial NCT01137695 · UNKNOWN

Trial details

NCT number: NCT01137695
Sponsor: Cheryl Rosenfeld, DO
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-05-01
Primary completion: 2012-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.